A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The study is designed to afford a safety and immunogenicity assessment of three Tetravalent Dengue Virus-Purified Inactivated Vaccine(TDENV-PIV) vaccine candidates.
Epistemonikos ID: dfe77a64586285915c2af43723ae607245ff11f9
First added on: Mar 23, 2020